Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy
Stefan Brenner(University of Vienna), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Juliane Riha(University of Vienna), Angelika Reiner(Donauspital), Erika Bajna(Medical University of Vienna), Madeleine Schölm(Medical University of Vienna), Christoph Ausch(Ludwig Boltzmann Institute for Cardiovascular Research), Walter Jäger, Lukas Klameth(Ludwig Boltzmann Institute for Cardiovascular Research), Theresia Thalhammer(Medical University of Vienna), Gerhard Hamilton(Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA)
Cited by 23
Related Papers
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
|Blood Cancer Journal|2015|273